"Thromboxane B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).
| Descriptor ID |
D013929
|
| MeSH Number(s) |
D10.251.355.255.100.825.810 D10.251.355.310.166.971.810
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thromboxane B2".
Below are MeSH descriptors whose meaning is more specific than "Thromboxane B2".
This graph shows the total number of publications written about "Thromboxane B2" by people in this website by year, and whether "Thromboxane B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thromboxane B2" by people in Profiles.
-
Kakouros N, Nazarian SM, Stadler PB, Kickler TS, Rade JJ. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery. J Am Heart Assoc. 2016 Mar 15; 5(3):e002615.
-
Schwartz JI, Musser BJ, Tanaka WK, Taggart WV, Mehta A, Gottesdiener KM, Greenberg HE. Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin. Clin Pharmacol Drug Dev. 2015 09; 4(5):337-45.
-
Faraday N, Yanek LR, Mathias R, Herrera-Galeano JE, Vaidya D, Moy TF, Fallin MD, Wilson AF, Bray PF, Becker LC, Becker DM. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1. Circulation. 2007 May 15; 115(19):2490-6.
-
Faraday N, Becker DM, Yanek LR, Herrera-Galeano JE, Segal JB, Moy TF, Bray PF, Becker LC. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. Am J Cardiol. 2006 Sep 15; 98(6):774-9.
-
De Candia E, Lanza GA, Romagnoli E, Ciabattoni G, Sestito A, Pasqualetti P, Crea F, Maseri A, Landolfi R. Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. Int J Cardiol. 2005 Apr 28; 100(3):371-6.
-
Van Solingen RM, Rosenstein ED, Mihailescu G, Drejka ML, Kalia A, Cohen AJ, Kramer N. Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin. Am J Med. 2001 Sep; 111(4):285-9.
-
Jaweed MM, Alam I, Herbison GJ, Ditunno JF. Changes in thromboxane B2 and 6-keto-PGF1 alpha after direct electrical stimulation of the denervated rat gastrocnemius1,2. Prostaglandins Leukot Med. 1982 Aug; 9(2):205-10.